Spatial Structure and Activity of Synthetic Fragments of Lynx1 and of Nicotinic Receptor Loop C Models.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
22 12 2020
Historique:
received: 08 10 2020
revised: 06 12 2020
accepted: 19 12 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 24 6 2021
Statut: epublish

Résumé

Lynx1, membrane-bound protein co-localized with the nicotinic acetylcholine receptors (nAChRs) and regulates their function, is a three-finger protein (TFP) made of three β-structural loops, similarly to snake venom α-neurotoxin TFPs. Since the central loop II of α-neurotoxins is involved in binding to nAChRs, we have recently synthesized the fragments of Lynx1 central loop, including those with the disulfide between Cys residues introduced at N- and C-termini, some of them inhibiting muscle-type nAChR similarly to the whole-size water-soluble Lynx1 (ws-Lynx1). Literature shows that the main fragment interacting with TFPs is the C-loop of both nAChRs and acetylcholine binding proteins (AChBPs) while some ligand-binding capacity is preserved by analogs of this loop, for example, by high-affinity peptide HAP. Here we analyzed the structural organization of these peptide models of ligands and receptors and its role in binding. Thus, fragments of Lynx1 loop II, loop C from the

Identifiants

pubmed: 33374963
pii: biom11010001
doi: 10.3390/biom11010001
pmc: PMC7821949
pii:
doi:

Substances chimiques

AChBP protein, Lymnaea 0
Adaptor Proteins, Signal Transducing 0
Bacterial Proteins 0
Bungarotoxins 0
Carrier Proteins 0
LYNX1 protein, human 0
Ligands 0
Neurotoxins 0
Peptides 0
Receptors, Nicotinic 0
hook protein, bacterial flagellum 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russian Science Foundation
ID : 16-14-00215p
Pays : International

Références

Neuron. 2002 Jul 18;35(2):319-32
pubmed: 12160749
Nat Struct Mol Biol. 2014 Nov;21(11):976-80
pubmed: 25282151
Biotechnol Bioeng. 1990 Feb 20;35(4):327-38
pubmed: 18592527
J Biomol NMR. 2004 Jul;29(3):299-308
pubmed: 15213428
FEBS Lett. 1999 Jul 9;454(3):293-8
pubmed: 10431825
Neuron. 2001 Oct 25;32(2):265-75
pubmed: 11683996
J Biol Chem. 2011 Mar 25;286(12):10618-27
pubmed: 21252236
Mol Pharmacol. 1988 Nov;34(5):643-50
pubmed: 3193956
Biochemistry. 2002 Feb 5;41(5):1457-63
pubmed: 11814338
Chem Biol. 2001 Feb;8(2):147-55
pubmed: 11251289
Curr Pharm Des. 2009;15(21):2430-52
pubmed: 19601841
Biochem J. 2019 Apr 26;476(8):1285-1302
pubmed: 30944155
Biochemistry. 1997 Feb 18;36(7):1678-88
pubmed: 9048551
Neuron. 2020 Jun 17;106(6):952-962.e5
pubmed: 32275860
J Biomol NMR. 2015 Aug;62(4):453-71
pubmed: 25801209
Front Pharmacol. 2019 Jul 03;10:748
pubmed: 31333465
Biochem J. 2003 Jun 1;372(Pt 2):543-54
pubmed: 12614199
Biochemistry (Mosc). 2017 Dec;82(13):1702-1715
pubmed: 29523067
Br J Pharmacol. 2018 Jun;175(11):1880-1891
pubmed: 28452148
J Biomol NMR. 2009 Aug;44(4):213-23
pubmed: 19548092
EMBO J. 2005 Apr 20;24(8):1512-22
pubmed: 15791209
Bioorg Khim. 1995 Feb;21(2):152-5
pubmed: 7748208
PLoS One. 2019 May 31;14(5):e0217339
pubmed: 31150435
Biochemistry. 1991 May 21;30(20):4925-34
pubmed: 2036361
Curr Pharm Des. 2016;22(14):2152-9
pubmed: 26818857
Sci Rep. 2020 Mar 2;10(1):3861
pubmed: 32123252
J Biomol NMR. 2009 Nov;45(3):295-9
pubmed: 19697137
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8280-5
pubmed: 18541920
Biochem J. 2019 May 28;476(10):1515-1520
pubmed: 31138769
Protein Sci. 2006 Dec;15(12):2795-804
pubmed: 17088319
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8790-4
pubmed: 3866252
Biochem Pharmacol. 2020 Nov;181:114168
pubmed: 32710970
Biochem Pharmacol. 2009 Oct 1;78(7):720-31
pubmed: 19501053
Trends Pharmacol Sci. 2015 Feb;36(2):109-23
pubmed: 25528970
J Biol Chem. 2002 Oct 4;277(40):37439-45
pubmed: 12133834
Biochem J. 2013 Sep 1;454(2):303-310
pubmed: 23800261
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6629-34
pubmed: 11381118
J Neurochem. 2020 Jul 10;:
pubmed: 32648941
Nat Neurosci. 2007 Aug;10(8):953-62
pubmed: 17643119
Biochemistry. 1998 Jul 7;37(27):9851-61
pubmed: 9657699
Biochim Biophys Acta. 2005 Aug 10;1751(2):119-39
pubmed: 16027053
J Magn Reson B. 1996 Apr;111(1):23-30
pubmed: 8661260
Front Pharmacol. 2019 Apr 30;10:343
pubmed: 31114495
J Am Chem Soc. 2005 Nov 2;127(43):14970-1
pubmed: 16248604
Neurochem Res. 2003 Apr;28(3-4):599-606
pubmed: 12675150

Auteurs

Konstantin S Mineev (KS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Department of Physico-Chemical Biology and Biotechnology, Moscow Institute of Physics and Technology, 141700 Dolgoprudnyi, Russia.

Elena V Kryukova (EV)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Igor E Kasheverov (IE)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Laboratory of Molecular Biology and Biochemistry, Institute of Molecular Medicine, Biomedical Science and Technology Park, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Natalia S Egorova (NS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Maxim N Zhmak (MN)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Igor A Ivanov (IA)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Dmitry A Senko (DA)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.

Alexey V Feofanov (AV)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Biological Faculty, Lomonosov Moscow State University, 119991 Moscow, Russia.

Anastasia A Ignatova (AA)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Alexander S Arseniev (AS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Yuri N Utkin (YN)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Victor I Tsetlin (VI)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Institute for Physics and Engineering in Biomedicine, National Research Nuclear University MEPhI, 115409 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH